These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
381 related articles for article (PubMed ID: 32670880)
1. Understanding the Mechanisms by Which Epigenetic Modifiers Avert Therapy Resistance in Cancer. Quagliano A; Gopalakrishnapillai A; Barwe SP Front Oncol; 2020; 10():992. PubMed ID: 32670880 [TBL] [Abstract][Full Text] [Related]
2. Epigenomics in stress tolerance of plants under the climate change. Kumar M; Rani K Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors. Xu QY; Yu L Chin Med J (Engl); 2020 Mar; 133(6):699-715. PubMed ID: 32044818 [TBL] [Abstract][Full Text] [Related]
4. Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets. Bajbouj K; Al-Ali A; Ramakrishnan RK; Saber-Ayad M; Hamid Q Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769131 [TBL] [Abstract][Full Text] [Related]
5. Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements. Singh D; Khan MA; Siddique HR Epigenomics; 2023 Apr; 15(8):517-537. PubMed ID: 37313832 [TBL] [Abstract][Full Text] [Related]
6. Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer. Facciotto C; Casado J; Turunen L; Leivonen SK; Tumiati M; Rantanen V; Kauppi L; Lehtonen R; Leppä S; Wennerberg K; Hautaniemi S Clin Epigenetics; 2019 Dec; 11(1):192. PubMed ID: 31829282 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors. Madkour MM; Ramadan WS; Saleh E; El-Awady R Ann Med; 2023 Dec; 55(1):2203946. PubMed ID: 37092854 [TBL] [Abstract][Full Text] [Related]
9. Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. Pearson AD; Stegmaier K; Bourdeaut F; Reaman G; Heenen D; Meyers ML; Armstrong SA; Brown P; De Carvalho D; Jabado N; Marshall L; Rivera M; Smith M; Adamson PC; Barone A; Baumann C; Blackman S; Buenger V; Donoghue M; Duncan AD; Fox E; Gadbaw B; Hattersley M; Ho P; Jacobs I; Kelly MJ; Kieran M; Lesa G; Ligas F; Ludwinski D; McDonough J; Nikolova Z; Norga K; Senderowicz A; Taube T; Weiner S; Karres D; Vassal G Eur J Cancer; 2020 Nov; 139():135-148. PubMed ID: 32992153 [TBL] [Abstract][Full Text] [Related]
10. Enhancing Therapeutic Approaches for Melanoma Patients Targeting Epigenetic Modifiers. Gracia-Hernandez M; Munoz Z; Villagra A Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944799 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy combinations in acute myeloid leukemia: what are the options? Bewersdorf JP; Shallis R; Stahl M; Zeidan AM Ther Adv Hematol; 2019; 10():2040620718816698. PubMed ID: 30719265 [TBL] [Abstract][Full Text] [Related]
12. Targeting Chromatin Remodeling for Cancer Therapy. Kaur J; Daoud A; Eblen ST Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757 [TBL] [Abstract][Full Text] [Related]
13. An insight into understanding the coupling between homologous recombination mediated DNA repair and chromatin remodeling mechanisms in plant genome: an update. Banerjee S; Roy S Cell Cycle; 2021 Sep; 20(18):1760-1784. PubMed ID: 34437813 [TBL] [Abstract][Full Text] [Related]
14. Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma. Yeon M; Kim Y; Jung HS; Jeoung D Front Cell Dev Biol; 2020; 8():486. PubMed ID: 32626712 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications. Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893 [TBL] [Abstract][Full Text] [Related]
16. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA. Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398 [TBL] [Abstract][Full Text] [Related]
17. Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression. Saleh R; Toor SM; Sasidharan Nair V; Elkord E Front Immunol; 2020; 11():1469. PubMed ID: 32760400 [TBL] [Abstract][Full Text] [Related]